Trust and the reputation of the pharmaceutical industry: has the pandemic made a difference?

Since the global pandemic, the public have had more exposure to the power of pharma companies to improve and save lives. The sector has also been exposed to an unprecedented level of mainstream media coverage. So the big question is; has this has led to a heightened degree of trust?

The author(s)
  • James Allen Corporate Reputation
  • Thomas Fife-Schaw Corporate Reputation
Get in touch

The pharmaceutical industry has been in the spotlight over the last 24 months helping us move from a society dominated by COVID-19 and lockdowns to one with freedom. 

Historically, the pharmaceutical industry has not always generated end-to-end trust nor exhibited transparency. As the sector has played a vital role in the development of vaccines and treatments for COVID-19, the tide seems to be turning in favour of pharmaceutical companies. Is this upturn sustainable? Or could gains in trust change once COVID-19 moves to a note in the history books? What is driving the changes that we are seeing? And why do perceptions of the industry tend to vary so greatly by regions, with levels of distrust and scepticism higher in certain countries?

In the short video above, Thomas Fife-Schaw, pharmaceutical sector lead in Ipsos’ Corporate Reputation team, uses data from the Ipsos Global Trustworthiness Monitor to explain. The full article within the report can be found here.

The author(s)
  • James Allen Corporate Reputation
  • Thomas Fife-Schaw Corporate Reputation

More insights about Health

Society